Healthpoint
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1971-01-01
- Employees
- 501
- Market Cap
- -
Effect of Collagenase on Healing and Scarring
Phase 4
Completed
- Conditions
- ScarringImpaired Wound Healing
- Interventions
- First Posted Date
- 2008-04-03
- Last Posted Date
- 2011-06-09
- Lead Sponsor
- Healthpoint
- Target Recruit Count
- 28
- Registration Number
- NCT00651820
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
- First Posted Date
- 2008-03-27
- Last Posted Date
- 2014-01-13
- Lead Sponsor
- Healthpoint
- Target Recruit Count
- 38
- Registration Number
- NCT00644917
Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
- First Posted Date
- 2008-03-27
- Last Posted Date
- 2010-06-08
- Lead Sponsor
- Healthpoint
- Target Recruit Count
- 59
- Registration Number
- NCT00645164
- Locations
- ๐บ๐ธ
Suncare Research Laboratories, Winston-Salem, North Carolina, United States
OASIS Wound Matrix (Oasis) Mechanism of Action
Phase 4
Completed
- Conditions
- Venous Stasis Ulcers (VSU)Diabetic Foot Ulcers (DFU)
- Interventions
- Device: OASIS Wound Matrix
- First Posted Date
- 2007-12-10
- Last Posted Date
- 2011-06-09
- Lead Sponsor
- Healthpoint
- Target Recruit Count
- 13
- Registration Number
- NCT00570141
- Locations
- ๐บ๐ธ
Bay Pines VA Healthcare System, St. Louis, Missouri, United States
๐บ๐ธSparks Regional Medical Center, Fort Smith, Arkansas, United States
๐บ๐ธDixie Regional Medical Center Wound Clinic, St. George, Utah, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath